Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Medicure Inc (TSV:MPH)

1.140 UNCHANGED
Streaming Delayed Price Updated: 9:30 AM EST, Feb 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 1.140
Bid (Size) 1.140 (56)
Ask (Size) 1.300 (9)
Prev. Close 1.140
Today's Range 1.140 - 1.140
52wk Range 0.6300 - 1.430
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Medicure Reports Financial Results for Quarter Ended September 30, 2025
Via ACCESS Newswire
News headline image
Medicure To Present Financial Results on November 20, 2025 Call at 8:30 AM ET for Quarter Ended September 30, 2025
Via ACCESS Newswire

Performance

YTD
N/A
N/A
1 Month
-3.4%
-3.4%
3 Month
-11.6%
-11.6%
6 Month
-0.9%
-0.9%
1 Year
+44.3%
+44.3%

More News

Read More
News headline image
Medicure Reports Financial Results for Quarter Ended June 30, 2025
Via ACCESS Newswire
News headline image
Medicure to Present Financial Results on August 21, 2025 Call at 8:30 am ET for Quarter Ended June 30, 2025
Via ACCESS Newswire
News headline image
Medicure Announces Closing of Purchase Agreement for The Acquisition of West Olympia Pharmacy
Via ACCESS Newswire
News headline image
Medicure Reports Financial Results for Quarter Ended March 31, 2025 and Annual General Meeting Director Election Results
Via ACCESS Newswire
News headline image
Medicure Reports Financial Results for Quarter and Year Ended December 31, 2024
Via ACCESS Newswire
News headline image
Medicure to Present Financial Results on April 29, 2025 Call at 8:30 AM ET for Quarter and Year Ended December 31, 2024
Via ACCESS Newswire
News headline image
Medicure Announces Further Expansion of Its Pharmacy Business Through Signing of a Purchase Agreement for the Acquisition of West Olympia Pharmacy
Via ACCESS Newswire
News headline image
Medicure Announces Closing of Purchase Agreement for the Acquisition of Gateway Medical Pharmacy
Via ACCESS Newswire
News headline image
Medicure Announces Expansion of Its Pharmacy Business Through Signing of a Purchase Agreement for the Acquisition of Gateway Medical Pharmacy
Via ACCESS Newswire
News headline image
Medicure Reports Financial Results For Quarter Ended September 30, 2024
Via ACCESSWIRE
News headline image
Medicure to Present Financial Results on November 26, 2024 Call at 8:30 AM ET for Quarter Ended September 30, 2024 and Announces Resignation of Board Member
Via ACCESSWIRE
News headline image
Medicure Announces Positive Settlement of Product Development and Supply Contracts
Via ACCESSWIRE
News headline image
Medicure Announces Closing of Asset Purchase Agreement with Canam Bioresearch for Acquisition of Intellectual Property
Via ACCESSWIRE
News headline image
Medicure Reports Financial Results for Quarter Ended June 30, 2024
Via ACCESSWIRE
News headline image
Medicure Announces Signing of Asset Purchase Agreement with CanAm Bioresearch Inc. for Acquisition of Intellectual Property
Via ACCESSWIRE
News headline image
Medicure Reports Financial Results for Quarter Ended March 31, 2024 and Annual General Meeting Director Election Results
Via ACCESSWIRE
News headline image
Medicure Receives US FDA Fast Track Designation for MC-1 for PNPO Deficiency
Via ACCESSWIRE
News headline image
Medicure Reports Financial Results for Quarter and Year Ended December 31, 2023
Via ACCESSWIRE
News headline image
Medicure To Present Financial Results on April 9, 2024 Call at 8:30 AM ET for Quarter and Year Ended December 31, 2023
Via ACCESSWIRE
News headline image
Medicure Announces New Partnership Through Its Marley Drug Subsidiary to Provide Brenzavvy(R) as an Affordable Medication for Americans with Type 2 Diabetes
Via ACCESSWIRE
News headline image
Medicure Announces FDA Provides Complete Approval to Enroll Patients in Its Pivotal Phase 3 Trial for Treatment of Rare Pediatric Disease
Via ACCESSWIRE
News headline image
Medicure Reports Financial Results for Quarter Ended September 30, 2023
Via ACCESSWIRE
News headline image
Medicure Reiterates its Commitment to Providing Exceptional Access to its Branded Pitavastatin (Zypitamag) to People Living With HIV
Via ACCESSWIRE

Frequently Asked Questions

Is Medicure Inc publicly traded?
Yes, Medicure Inc is publicly traded.
What exchange does Medicure Inc trade on?
Medicure Inc trades on the Toronto Venture Stock Exchange
What is the ticker symbol for Medicure Inc?
The ticker symbol for Medicure Inc is MPH on the Toronto Venture Stock Exchange
What is the current price of Medicure Inc?
The current price of Medicure Inc is 1.140
When was Medicure Inc last traded?
The last trade of Medicure Inc was at 02/10/26 09:30 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS